152 related articles for article (PubMed ID: 29921210)
1. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
[TBL] [Abstract][Full Text] [Related]
2. Off-label drug prescriptions in French general practice: a cross-sectional study.
Drogou F; Netboute A; Giai J; Dode X; Darmon D; Kassai B; Letrilliart L
BMJ Open; 2019 Apr; 9(4):e026076. PubMed ID: 30967407
[TBL] [Abstract][Full Text] [Related]
3. Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review.
Oshikoya KA; Wharton GT; Avant D; Van Driest SL; Fenn NE; Lardieri A; Doe E; Sood BG; Taketomo C; Lieu P; Yen L; McMahon AW
Paediatr Drugs; 2019 Feb; 21(1):47-58. PubMed ID: 30484072
[TBL] [Abstract][Full Text] [Related]
4. PAttern of drug use in PEdiatrics: An observational study in Italian hOSpitals (the PAPEOS study).
Di Salvo M; Santi Laurini G; Motola D; Valpiani G; Sapigni E; Pompilio A; Arzenton E; Marra A
Br J Clin Pharmacol; 2024 Apr; 90(4):1050-1057. PubMed ID: 38163762
[TBL] [Abstract][Full Text] [Related]
5. Paediatric off-label use of drugs in Gansu, China: a multicentre cross-sectional study.
Meng M; Ge B; Lei W; Wu Y; Tian M; Lu Y; Shao T; Yang Y; Luo X; Luo J; Gao Y; Li Q; Chen Y
BMJ Open; 2024 May; 14(5):e078126. PubMed ID: 38740506
[TBL] [Abstract][Full Text] [Related]
6. Paracetamol prescribing in primary care: too little and too much?
Kazouini A; Mohammed BS; Simpson CR; Helms PJ; McLay JS
Br J Clin Pharmacol; 2011 Sep; 72(3):500-4. PubMed ID: 21592184
[TBL] [Abstract][Full Text] [Related]
7. A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs.
Smithburger PL; Buckley MS; Culver MA; Sokol S; Lat I; Handler SM; Kirisci L; Kane-Gill SL
Crit Care Med; 2015 Aug; 43(8):1612-21. PubMed ID: 25855897
[TBL] [Abstract][Full Text] [Related]
8. Clinical symptoms and 'off-label' prescribing in children with asthma.
McCowan C; Hoskins G; Neville RG
Br J Gen Pract; 2007 Mar; 57(536):220-2. PubMed ID: 17359609
[TBL] [Abstract][Full Text] [Related]
9. Prescription of off-label and unlicensed drugs for preterm infants in a neonatal intensive care unit.
Vieira VC; Costa RS; Lima RCG; Queiroz DB; Medeiros DS
Rev Bras Ter Intensiva; 2021; 33(2):266-275. PubMed ID: 34231807
[TBL] [Abstract][Full Text] [Related]
10. The Safety of Drug Therapy in Children.
Wimmer S; Neubert A; Rascher W
Dtsch Arztebl Int; 2015 Nov; 112(46):781-7. PubMed ID: 26806565
[TBL] [Abstract][Full Text] [Related]
11. Ten common questions (and their answers) about off-label drug use.
Wittich CM; Burkle CM; Lanier WL
Mayo Clin Proc; 2012 Oct; 87(10):982-90. PubMed ID: 22877654
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of off-label drug uses in hospitals: a multicentric prospective study.
Danés I; Agustí A; Vallano A; Alerany C; Martínez J; Bosch JA; Ferrer A; Gratacós L; Pérez A; Olmo M; Marron SM; Valderrama A; Bonafont X
Eur J Clin Pharmacol; 2014 Nov; 70(11):1385-93. PubMed ID: 25196202
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of off-label medication use and drug safety in a pediatric intensive care unit.
Lee S; Yang MH; Kim JS; Cho Y; Choi N; Cho EJ; Park JD; Choi YH; Choi KH
Saudi Pharm J; 2023 Sep; 31(9):101704. PubMed ID: 37520675
[TBL] [Abstract][Full Text] [Related]
14. Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit.
Santos LGD; Santos JGD; Iser BM; Kock KS; Bó KD
Rev Paul Pediatr; 2023; 42():e2023023. PubMed ID: 37729244
[TBL] [Abstract][Full Text] [Related]
15. Assessing National Trends and Perceived Safety of Off-Label Ciprofloxacin-Dexamethasone Use by Pediatric Otolaryngologists.
Shah HP; Shah R; Lockwood D; Yang N; Rohrbaugh T; Rutter MJ; Maurrasse SE
Laryngoscope; 2024 Jun; 134(6):2922-2930. PubMed ID: 38149706
[TBL] [Abstract][Full Text] [Related]
16. Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System.
Mascolo A; Scavone C; Bertini M; Brusco S; Punzo F; Pota E; Di Martino M; Di Pinto D; Rossi F
Front Pharmacol; 2020; 11():621. PubMed ID: 32457620
[TBL] [Abstract][Full Text] [Related]
17. Global shortage of neonatal and paediatric antibiotic trials: rapid review.
Thompson G; Barker CI; Folgori L; Bielicki JA; Bradley JS; Lutsar I; Sharland M
BMJ Open; 2017 Oct; 7(10):e016293. PubMed ID: 29030411
[TBL] [Abstract][Full Text] [Related]
18. Utilization of biotechnological drugs in rare diseases requiring the use of off-label drugs in children in Turkey.
Kırmızı Nİ; Aydın V; Akıcı N; Bayar B; Akıcı A
Turk J Med Sci; 2021 Aug; 51(4):1791-1799. PubMed ID: 33600094
[TBL] [Abstract][Full Text] [Related]
19. Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.
Naji-Talakar S; Sharma S; Martin LA; Barnhart D; Prasad B
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):273-289. PubMed ID: 33256492
[No Abstract] [Full Text] [Related]
20. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres.
Pouyanne P; Haramburu F; Imbs JL; Bégaud B
BMJ; 2000 Apr; 320(7241):1036. PubMed ID: 10764362
[No Abstract] [Full Text] [Related]
[Next] [New Search]
